| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjuvant Proton Beam Therapy in the Management of Thymoma: A Dosimetric Comparison and Acute Toxicities
|
Parikh, Rahul R.
|
|
2016
|
17 |
5 |
p. 362-366
5 p.
|
artikel
|
| 2 |
Anaplastic Lymphoma Kinase (ALK) Kinase Domain Mutation Following ALK Inhibitor(s) Failure in Advanced ALK Positive Non–Small-Cell Lung Cancer: Analysis and Literature Review
|
Lin, Yen-Ting
|
|
2016
|
17 |
5 |
p. e77-e94
nvt p.
|
artikel
|
| 3 |
Application of Lepidic Component Predominance to Adjuvant Chemotherapy with Oral Fluoropyrimidines for Stage I Lung Adenocarcinoma
|
Sasada, Shinsuke
|
|
2016
|
17 |
5 |
p. 433-440.e1
3968 p.
|
artikel
|
| 4 |
Assessment of Selection Criteria for Low-Dose Lung Screening CT Among Asian Ethnic Groups in Taiwan: From Mass Screening to Specific Risk-Based Screening for Non-Smoker Lung Cancer
|
Wu, Fu-Zong
|
|
2016
|
17 |
5 |
p. e45-e56
nvt p.
|
artikel
|
| 5 |
BEVERLY: Rationale and Design of a Randomized Open-Label Phase III Trial Comparing Bevacizumab Plus Erlotinib Versus Erlotinib Alone as First-Line Treatment of Patients With EGFR-Mutated Advanced Nonsquamous Non–Small-Cell Lung Cancer
|
Gridelli, Cesare
|
|
2016
|
17 |
5 |
p. 461-465
5 p.
|
artikel
|
| 6 |
Biomarkers for PD-1/PD-L1 Blockade Therapy in Non–Small-cell Lung Cancer: Is PD-L1 Expression a Good Marker for Patient Selection?
|
Chae, Young Kwang
|
|
2016
|
17 |
5 |
p. 350-361
12 p.
|
artikel
|
| 7 |
Cetuximab Inhibits T790M-Mediated Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in a Lung Adenocarcinoma Patient-Derived Xenograft Mouse Model
|
Martin, Petra
|
|
2016
|
17 |
5 |
p. 375-383.e2
37926 p.
|
artikel
|
| 8 |
Characteristics and Clinical Outcomes of Sarcomatoid Carcinoma of the Lung
|
Ung, Mony
|
|
2016
|
17 |
5 |
p. 391-397
7 p.
|
artikel
|
| 9 |
Clinical Impact of Gastric Acid-Suppressing Medication Use on the Efficacy of Erlotinib and Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer Harboring EGFR Mutations
|
Zenke, Yoshitaka
|
|
2016
|
17 |
5 |
p. 412-418
7 p.
|
artikel
|
| 10 |
Clinical Outcomes and Prognostic Factors of High-Dose Proton Beam Therapy for Peripheral Stage I Non-Small-Cell Lung Cancer
|
Hatayama, Yoshiomi
|
|
2016
|
17 |
5 |
p. 427-432
6 p.
|
artikel
|
| 11 |
Comprehensive Genomic Profiling Differentiates Metachronous Primary Small-Cell Lung Cancer From Late Recurrence
|
Gao, Xin
|
|
2016
|
17 |
5 |
p. e169-e172
nvt p.
|
artikel
|
| 12 |
Detection of Epidermal Growth Factor Receptor Mutations in Lung Adenocarcinoma: Comparing Cobas 4800 EGFR Assay With Sanger Bidirectional Sequencing
|
Ardakani, Nima Mesbah
|
|
2016
|
17 |
5 |
p. e113-e119
nvt p.
|
artikel
|
| 13 |
Diagnostic Value of Bronchoalveolar Lavage for Diagnosis of Suspected Peripheral Lung Cancer
|
Bezel, Pascal
|
|
2016
|
17 |
5 |
p. e151-e156
nvt p.
|
artikel
|
| 14 |
Dramatic Antitumor Activity of Nivolumab in Advanced HER2-Positive Lung Cancer
|
Catania, Chiara
|
|
2016
|
17 |
5 |
p. e179-e183
nvt p.
|
artikel
|
| 15 |
Editorial Board
|
|
|
2016
|
17 |
5 |
p. A7-
1 p.
|
artikel
|
| 16 |
Evaluating Intensity-Modulated Radiation Therapy in Locally Advanced Non–Small-Cell Lung Cancer: Results From the National Cancer Data Base
|
Jegadeesh, Naresh
|
|
2016
|
17 |
5 |
p. 398-405
8 p.
|
artikel
|
| 17 |
Impact of Age on Long-Term Outcomes of Surgery for Malignant Pleural Mesothelioma
|
Yang, Chi-Fu Jeffrey
|
|
2016
|
17 |
5 |
p. 419-426
8 p.
|
artikel
|
| 18 |
Large Cell Neuroendocrine Carcinoma of the Lung: Clinico-Pathologic Features, Treatment, and Outcomes
|
Naidoo, Jarushka
|
|
2016
|
17 |
5 |
p. e121-e129
nvt p.
|
artikel
|
| 19 |
Letter to the Editor
|
Tamura, Tomohiro
|
|
2016
|
17 |
5 |
p. e185-
1 p.
|
artikel
|
| 20 |
Lung Adenocarcinoma Staging Using the 2011 IASLC/ATS/ERS Classification: A Pooled Analysis of Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma
|
Behera, Madhusmita
|
|
2016
|
17 |
5 |
p. e57-e64
nvt p.
|
artikel
|
| 21 |
Meta-Analysis of First-Line Pemetrexed Plus Platinum Treatment in Compared to Other Platinum-Based Doublet Regimens in Elderly East Asian Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer
|
Lu, Shun
|
|
2016
|
17 |
5 |
p. e103-e112
nvt p.
|
artikel
|
| 22 |
MicroRNA-126 Targeting PIK3R2 Inhibits NSCLC A549 Cell Proliferation, Migration, and Invasion by Regulation of PTEN/PI3K/AKT Pathway
|
Song, Lei
|
|
2016
|
17 |
5 |
p. e65-e75
nvt p.
|
artikel
|
| 23 |
Monitoring and Characterization of Circulating Tumor Cells (CTCs) in a Patient With EML4-ALK–Positive Non–Small Cell Lung Cancer (NSCLC)
|
Aieta, Michele
|
|
2016
|
17 |
5 |
p. e173-e177
nvt p.
|
artikel
|
| 24 |
Neoadjuvant Oncogene-Targeted Therapy in Early Stage Non–Small-Cell Lung Cancer as a Strategy to Improve Clinical Outcome and Identify Early Mechanisms of Resistance
|
McCoach, Caroline E.
|
|
2016
|
17 |
5 |
p. 466-469
4 p.
|
artikel
|
| 25 |
No Advantage in Survival With Targeted Therapies as Maintenance in Patients With Limited and Extensive-Stage Small Cell Lung Cancer: A Literature-Based Meta-Analysis of Randomized Trials
|
Roviello, Giandomenico
|
|
2016
|
17 |
5 |
p. 334-340
7 p.
|
artikel
|
| 26 |
Nonsquamous, Non-Small-Cell Lung Cancer Patients Who Carry a Double Mutation of EGFR, EML4-ALK or KRAS: Frequency, Clinical-Pathological Characteristics, and Response to Therapy
|
Ulivi, Paola
|
|
2016
|
17 |
5 |
p. 384-390
7 p.
|
artikel
|
| 27 |
Prognostic Impact of Multiple Clinicopathologic Risk Factors and c-MET Overexpression in Patients Who Have Undergone Resection of Stage IB Non–Small-Cell Lung Cancer
|
Kim, In-Ho
|
|
2016
|
17 |
5 |
p. e31-e43
nvt p.
|
artikel
|
| 28 |
Proportion of Non–Small-Cell Lung Cancer Patients that Would Have Been Eligible for Lung Cancer Screening
|
Wu, Geena X.
|
|
2016
|
17 |
5 |
p. e131-e139
nvt p.
|
artikel
|
| 29 |
Psychological Burden Associated With Lung Cancer Screening: A Systematic Review
|
Wu, Geena X.
|
|
2016
|
17 |
5 |
p. 315-324
10 p.
|
artikel
|
| 30 |
Quality of Life After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer: A Systematic Review
|
Chen, Hanbo
|
|
2016
|
17 |
5 |
p. e141-e149
nvt p.
|
artikel
|
| 31 |
Radiomic Features Are Associated With EGFR Mutation Status in Lung Adenocarcinomas
|
Liu, Ying
|
|
2016
|
17 |
5 |
p. 441-448.e6
4.4799956E8 p.
|
artikel
|
| 32 |
Relevance of a Geriatric Assessment for Elderly Patients With Lung Cancer—A Systematic Review
|
Schulkes, Karlijn J.G.
|
|
2016
|
17 |
5 |
p. 341-349.e3
348660 p.
|
artikel
|
| 33 |
Reply
|
Kocher, Florian
|
|
2016
|
17 |
5 |
p. e187-
1 p.
|
artikel
|
| 34 |
Risk Factors for Local and Distant Recurrence After Surgical Treatment in Patients With Non–Small-Cell Lung Cancer
|
Dziedzic, Dariusz Adam
|
|
2016
|
17 |
5 |
p. e157-e167
nvt p.
|
artikel
|
| 35 |
SCLC–State of the Art and What Does the Future Have in Store?
|
Kahnert, Kathrin
|
|
2016
|
17 |
5 |
p. 325-333
9 p.
|
artikel
|
| 36 |
Sequential Serum Let-7 Is a Novel Biomarker to Predict Accelerated Reproliferation During Fractional Radiotherapy in Lung Cancer
|
Xie, Peng
|
|
2016
|
17 |
5 |
p. e95-e101
nvt p.
|
artikel
|
| 37 |
Table of Contents
|
|
|
2016
|
17 |
5 |
p. A18, A21-A25
|
artikel
|
| 38 |
The Fate of Residual Tumor Masses That Persist After Stereotactic Body Radiotherapy for Solitary Lung Nodules: Will They Recur?
|
Takenaka, Ran
|
|
2016
|
17 |
5 |
p. 406-411
6 p.
|
artikel
|
| 39 |
Treatment Patterns for Advanced Non–Small-cell Lung Cancer After Platinum-containing Therapy in U.S. Community Oncology Clinical Practice
|
McKay, Caroline
|
|
2016
|
17 |
5 |
p. 449-460.e7
4.599999552E9 p.
|
artikel
|
| 40 |
Weekly nab-Paclitaxel in Combination With Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Analysis of Safety and Efficacy in Patients With Diabetes
|
Hirsh, Vera
|
|
2016
|
17 |
5 |
p. 367-374
8 p.
|
artikel
|
Tijdschrift beschrijving